- Home
- AGMH vs SXTP Comparison
AGMH vs SXTP Comparison
Compare AGMH & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGMH
- SXTP
- Stock Information
- Founded
- AGMH 2015
- SXTP 2010
- Country
- AGMH Hong Kong
- SXTP United States
- Employees
- AGMH N/A
- SXTP N/A
- Industry
- AGMH EDP Services
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- AGMH Technology
- SXTP Health Care
- Exchange
- AGMH Nasdaq
- SXTP Nasdaq
- Market Cap
- AGMH 6.5M
- SXTP 6.7M
- IPO Year
- AGMH 2018
- SXTP 2023
- Fundamental
- Price
- AGMH $3.33
- SXTP $1.24
- Analyst Decision
- AGMH
- SXTP Buy
- Analyst Count
- AGMH 0
- SXTP 2
- Target Price
- AGMH N/A
- SXTP $3.00
- AVG Volume (30 Days)
- AGMH 54.3K
- SXTP 77.2K
- Earning Date
- AGMH 12-04-2025
- SXTP 11-14-2025
- Dividend Yield
- AGMH N/A
- SXTP N/A
- EPS Growth
- AGMH N/A
- SXTP N/A
- EPS
- AGMH 16.43
- SXTP N/A
- Revenue
- AGMH $48,526,743.00
- SXTP $984,494.00
- Revenue This Year
- AGMH N/A
- SXTP $81.41
- Revenue Next Year
- AGMH N/A
- SXTP $83.17
- P/E Ratio
- AGMH $0.16
- SXTP N/A
- Revenue Growth
- AGMH 18.80
- SXTP 128.70
- 52 Week Low
- AGMH $1.09
- SXTP $1.18
- 52 Week High
- AGMH $97.00
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- AGMH 33.74
- SXTP 35.39
- Support Level
- AGMH $3.18
- SXTP $1.18
- Resistance Level
- AGMH $3.58
- SXTP $1.29
- Average True Range (ATR)
- AGMH 0.31
- SXTP 0.06
- MACD
- AGMH -0.07
- SXTP -0.02
- Stochastic Oscillator
- AGMH 8.55
- SXTP 14.62
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.